Upon neuroaxonal injury, NfL is released into the cerebrospinal fluid (CSF) and peripheral blood, underscoring its value in neurological disorders such as ischemic stroke, Alzheimer’s disease (AD), and multiple sclerosis (19, 20). This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.